Take-private sale of the company to Battery Ventures
Sale of its Genie Division to Troemner, LLC, a subsidiary of Mettler-Toledo
Sale of the company to Werfen
Acquisition of A4P Bio
Sale of the company to Oncodesign Services
Acquistion of celares GmBH
Sale of the company to Medix Biochemica
Sale of the company to Biosynth Carbosynth
Acquisition of FlowMetric
Aquisition of antibodies-online
Sale of the company to Maravai LifeSciences
Sale of the company to Cytek Biosciences
Sale of the company to Element Materials Technology
Sale of the company to Element Materials Technology
Sale of the company to Vitruvian
Sale of the company to Versiti
Sale of the company to BioLife Solutions
Sale of the company to PerkinElmer
Sale of company to Thompson Street Capital Partners
Sale of the company to LGC Limited
Sale of the company to Thermo Fisher Scientific Inc.
Sale of the company to Unchained Labs
Exclusive placement agent for Labconnect, Inc.
Sale of the company to Takara Bio Inc.
Sale of the company to Thermo Fisher Scientific Inc.
Strategic acquisition of Cygnus
Strategic acquisition of TriLink Biotechnologies
Sale of the company to PerkinElmer
Clarity Medical Systems has sold its RetCam Ophthalmic Imaging System business to Natus Medical
Sale of the company to Lab Corporation of America
Strategic equity investment in Vector Laboratories
Sale of the company to OpGen, Inc.
Sale of the iPS Cell Business Unit of Stemgent ReproCELL, Inc.
Sale of miRInform Thyroid and Pancrease Test to PDI Inc. (now Interpace Diagnostics)
Sale of company to StoneCalibre
Equity investment and strategic collaboration with Brooks Automation, Inc.
Sale of in-vivo preclinical services business to BIOQUAL, Inc.
Sale of sequencing services business to BioReference Laboratories, Inc.
Sale of the Life Science business of SDIX to OriGene Technologies, Inc.
Sale of UVP LLC to Analytik Jena AG
Sale of BioServices business to Precision Bioservices
Sale of Food Safety and GMO businesses to Romer Labs
Sale of preclinical in-vivo imaging business to Bruker
Exclusive placement agent for OpGen, Inc.
BroadOak Partners provided financial advisory services to Quanta Biosciences
Non-exclusive license agreement with QIAGEN
BroadOak retained to provide ongoing financial advisory services
SVT gains exclusive rights in China to ENMD-2076 through investment in EntreMed, Inc.
Replacement and expansion of Cayman Chemical Company's debt facilities
Acquisition of Hyaluron, Inc.
Acquisition of GlobalStem, Inc.
Sale of in-vivo preclinical CRO services business to Taconic Farms, Inc.
Sale of Alpha Innotech Corp. to Cell Bioscience
Collaboration and license agreement with Novartis
Sale of non-core assets to Intrexon Corporation
Sale of Assay Designs, Inc. to Enzo Biochem, Inc.
Sale of Semrock Inc. to IDEX Corp
Sale of Fluorescent Detection Products Business
Acquisition of biodefense vaccines business from Avecia Biologics Limited
Sale of In Vitro Technologies, Inc to Celsis International Plc
Acquisition of sales and marketing rights to EpiPen in Canada from Allerex Laboratory
Acquisition of Control Delivery Systems
Sale of NovaScreen Biosciences to Caliper Life Sciences
“
We believe true success for our companies comes from supporting the management team first.
Robert Wicke
Operating Partner
